A Study of Liposomal Bupivacaine Versus 0.25% Bupivacaine Hydrochloride Post Breast Reduction

Condition:   Breast Reduction Interventions:   Drug: Bupivacaine Hydrochloride;   Drug: Liposomal Bupivacaine Sponsor:   Mayo Clinic Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials